NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome

Tatsuaki Kurosaki1,2, Hitomi Sakano3,4, Christoph Pröschel5,6

  • 1Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, 14642, USA.

Genome Biology
|November 17, 2021
PubMed
Abstract

Insights

Fragile X syndrome (FXS) involves intellectual disability due to FMRP loss. This study shows hyperactivated nonsense-mediated mRNA decay (NMD) in FXS mouse models, impacting brain development and highlighting the need for early intervention.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Fragile X syndrome (FXS) is an intellectual disability caused by the loss of fragile X protein (FMRP).
  • FMRP loss leads to hyperactivated nonsense-mediated mRNA decay (NMD) and impaired neuronal differentiation in human stem cells.

Purpose of the Study:

  • To investigate NMD activity during brain development in a mouse model of FXS.
  • To identify neuronal mRNAs regulated by NMD and affected by FMRP loss.

Main Methods:

  • Utilized Fmr1-knockout (KO) mice, a model for FXS.
  • Examined NMD activity in the developing cerebral cortex, hippocampus, and cerebellum.
  • Analyzed the regulation of neuronal mRNAs during embryonic and early postnatal periods.

Main Results:

  • Nonsense-mediated mRNA decay (NMD) is hyperactivated in the developing brain of Fmr1-KO mice.
  • NMD regulates numerous neuronal mRNAs crucial for mouse brain development.
  • Abnormal mRNA regulation was observed in the Fmr1-KO mouse model.

Conclusions:

  • FMRP loss leads to hyperactivated NMD during critical periods of brain development.
  • Dysregulated NMD impacts neuronal mRNA homeostasis in FXS.
  • Early intervention strategies may be crucial for mitigating FXS-related developmental deficits.

Related Concept Videos